Serotoninergic Receptor Ligands Improve Tamoxifen Effectiveness on Breast Cancer Cells

Researchers investigated the effect of 10 serotoninergic receptor ligands on viability of MCF7, SKBR3 and MDA-MB231 breast cancer cells and focused on their potential ability to affect Tamoxifen responsiveness in ER+ cells.